The Experts below are selected from a list of 612 Experts worldwide ranked by ideXlab platform
J Evans - One of the best experts on this subject based on the ideXlab platform.
-
a comparative trial of bifonazole 1 cream and clotrimazole 1 cream in the treatment of candidal Balanoposthitis eine vergleichsstudie von bifonazol 1 creme mit clotrimazol 1 creme in der behandlung der candida Balanoposthitis
Mycoses, 2009Co-Authors: R D Maw, T Horner, J EvansAbstract:Summary: One hundred patients with a diagnosis of candidal Balanoposthitis were treated using either Bifonazole 1% cream or Clotrimazole 1% cream on a randomized basis. Fifty patients (Group A) received Bifonazole 1% to be applied once only per day for six days, the remaining 50 received Clotrimazole 1% (Group B) to be applied twice daily for six days. Follow-up at day 7 after exclusion, showed that 21 of 27 patients (77.8%) in Group A and 20 of 26 patients (76.9%) in Group B had negative mycology cultures. Second follow-up at day 35 in 13 cases from Group A showed one patient (7.7%) had relapsed and of 15 cases in Group B one patient (5.6%) had relapsed. There was no significant difference observed in the results of treatment in these two groups at one week or five week follow-up studies. Zusammenfassung Einhundert Patienten mit der Diagnose einer Candida-Balanoposthitis wurden randomisiert entweder mit Bifonazol 1% Creme oder Clotrimazol 1% Creme behandelt. Funfzig Patienten (Gruppe A) erhielten biffonazol 1% zur einmaligen Anwendung pro Tag sechs Tage lang. Die restlichen funfzig erhielten Clotrimazol 1% (Gruppe B) zur zweimaligen Anwendung pro Tag sechs Tage lang. Die Nachuntersuchung am 7. Tag nach Absetzen der Behandlung ergab, das 21 von 27 Patienten (77,8%) in Gruppe A und 20 von 25 Patienten (76,9%) in Gruppe B negative Pilzkulturen aufwiesen. Die zweite Nachuntersuchung am 35. Tag ergab, das von 13 Fallen in Gruppe A ein Patient (7,7%) rezidiviert hatte und in Gruppe B von 15 Fallen ein Patient (5,6%) rezidiviert hatte. In den Nachuntersuchungen nach einer Woche und nach 5 Wochen wurde bei diesen beiden Gruppen kein wesentlicher Unterschied im Ergebnis der Behandlung beobachtet.
R D Maw - One of the best experts on this subject based on the ideXlab platform.
-
a comparative trial of bifonazole 1 cream and clotrimazole 1 cream in the treatment of candidal Balanoposthitis eine vergleichsstudie von bifonazol 1 creme mit clotrimazol 1 creme in der behandlung der candida Balanoposthitis
Mycoses, 2009Co-Authors: R D Maw, T Horner, J EvansAbstract:Summary: One hundred patients with a diagnosis of candidal Balanoposthitis were treated using either Bifonazole 1% cream or Clotrimazole 1% cream on a randomized basis. Fifty patients (Group A) received Bifonazole 1% to be applied once only per day for six days, the remaining 50 received Clotrimazole 1% (Group B) to be applied twice daily for six days. Follow-up at day 7 after exclusion, showed that 21 of 27 patients (77.8%) in Group A and 20 of 26 patients (76.9%) in Group B had negative mycology cultures. Second follow-up at day 35 in 13 cases from Group A showed one patient (7.7%) had relapsed and of 15 cases in Group B one patient (5.6%) had relapsed. There was no significant difference observed in the results of treatment in these two groups at one week or five week follow-up studies. Zusammenfassung Einhundert Patienten mit der Diagnose einer Candida-Balanoposthitis wurden randomisiert entweder mit Bifonazol 1% Creme oder Clotrimazol 1% Creme behandelt. Funfzig Patienten (Gruppe A) erhielten biffonazol 1% zur einmaligen Anwendung pro Tag sechs Tage lang. Die restlichen funfzig erhielten Clotrimazol 1% (Gruppe B) zur zweimaligen Anwendung pro Tag sechs Tage lang. Die Nachuntersuchung am 7. Tag nach Absetzen der Behandlung ergab, das 21 von 27 Patienten (77,8%) in Gruppe A und 20 von 25 Patienten (76,9%) in Gruppe B negative Pilzkulturen aufwiesen. Die zweite Nachuntersuchung am 35. Tag ergab, das von 13 Fallen in Gruppe A ein Patient (7,7%) rezidiviert hatte und in Gruppe B von 15 Fallen ein Patient (5,6%) rezidiviert hatte. In den Nachuntersuchungen nach einer Woche und nach 5 Wochen wurde bei diesen beiden Gruppen kein wesentlicher Unterschied im Ergebnis der Behandlung beobachtet.
Sang Don Lee - One of the best experts on this subject based on the ideXlab platform.
-
Effect of Topical Steroid (0.05 % Clobetasol Propionate) Treatment
2016Co-Authors: In Children Severe Phimosis, Chan Ho Lee, Sang Don LeeAbstract:Purpose: We report our experience with the use of a topical steroid, 0.05 % clobetasol propionate, for the treatment of phimosis with clinical complications. Materials and Methods: This was a retrospective analysis of the clinical outcomes of all patients presenting with phimosis to a single institution during the time period from October 2008 to May 2012. A total of 88 patients who had a Kikiros retractability grade of 4 or 5 and phimosis-associated clinical complications, such as ballooning of the pre-puce, Balanoposthitis, or a history of urinary tract infection (UTI), were instructed to apply 0.05 % clobetasol propionate cream to the slightly retracted foreskin and to mas-sage gently while retracting the foreskin. The efficacy of treatment was evaluated at 4 weeks from the initiation of therapy. Results: A total of 60 of the 88 patients (68.2%) showed a complete response (i.e., full retraction of the foreskin) to the therapy. The phimotic ring disappeared in 25 of the 88 patients (28.4%) after treatment. Patients who had a history of Balanoposthitis, smegma, ballooning of the prepuce, or UTI showed significantly poorer improvement in preputial retraction (p＜0.001, p＜0.001, p＜0.001, and p=0.02, respectively) and phimotic ring disappearance (p＜0.001, p=0.001, p＜0.001, and p=0.001, respectively) after treatment. No significant local or systemic side effects were associated with the administration of topical steroids. Conclusions: Topical application of 0.05 % clobetasol propionate cream and skin stretch-ing is a safe, simple, and effective procedure with no significant side effects for severe phimosis in prepubertal boys
-
effect of topical steroid 0 05 clobetasol propionate treatment in children with severe phimosis
Korean Journal of Urology, 2013Co-Authors: Chan Ho Lee, Sang Don LeeAbstract:88 patients (28.4%) after treatment. Patients who had a history of Balanoposthitis, smegma, ballooning of the prepuce, or UTI showed significantly poorer improvement in preputial retraction (p＜0.001, p＜0.001, p＜0.001, and p=0.02, respectively) and phimotic ring disappearance (p＜0.001, p=0.001, p＜0.001, and p=0.001, respectively) after treatment. No significant local or systemic side effects were associated with the administration of topical steroids. Conclusions: Topical application of 0.05% clobetasol propionate cream and skin stretching is a safe, simple, and effective procedure with no significant side effects for severe phimosis in prepubertal boys.
Uwe Wollina - One of the best experts on this subject based on the ideXlab platform.
-
looking through the cracks of diabetic candidal Balanoposthitis
International Journal of General Medicine, 2011Co-Authors: Shyam B Verma, Uwe WollinaAbstract:India is becoming an epicentre of type II diabetes mellitus with a crude prevalence rate of about 9%. Candida Balanoposthitis is a known feature of diabetes mellitus especially in Indian males who are predominantly uncircumcised. In this country, diabetes is often diagnosed for the first time by dermatologists. Diabetes is much more frequently the cause of candida Balanoposthitis than sexual intercourse in India. Fissuring along with Balanoposthitis was found to be more common in sexually active males. The biomechanical basis of fissuring and the effect of diabetes in this phenomenon are explained. The issue of circumcision is debated under various aspects.
-
ablative erbium yag laser treatment of idiopathic chronic inflammatory non cicatricial Balanoposthitis zoon s disease a series of 20 patients with long term outcome
Journal of Cosmetic and Laser Therapy, 2010Co-Authors: Uwe WollinaAbstract:AbstractBackground: Chronic inflammatory non-cicatricial balanitis/Balanoposthitis (Zoon 1952) is not uncommon among aged uncircumcised males. The course is chronic and will lead to severe epidermal atrophy. This disease is poorly responsive to topical treatment. The golden standard for treatment is circumcision. Objective: This study was performed to evaluate the efficacy and safety of ablative erbium:YAG laser treatment. Methods: An uncontrolled trial was performed with 20 Caucasian male patients (mean age 64.8 years) who presented with chronic inflammatory non-cicatricial balanitis or Balanoposthitis. The patients received multiple topical treatments. The disease duration ranged from 1 to more than 7 years. Diagnosis was confirmed by histology. Topical anaesthesia was performed before erbium:YAG laser ablation (focus 1.6–5 mm; frequency 8 Hz; impulse energy mostly 800 mJ; fluence between 11.3 and 20 J cm−2). The pulses were partly overlapping. The pain sensation was recorded by visual analogue scale (V...
Ichiro Tatsuno - One of the best experts on this subject based on the ideXlab platform.
-
characterisation of clinically isolated streptococcus pyogenes from Balanoposthitis patients with special emphasis on emm89 isolates
Journal of Medical Microbiology, 2017Co-Authors: Tadao Hasegawa, Hideyuki Matsui, Masanori Isaka, Nanako Hata, Ichiro TatsunoAbstract:Purpose. Streptococcus pyogenes causes a variety of diseases, such as pharyngitis and toxic shock syndrome. In addition, this bacterium is a causative agent of Balanoposthitis. To reveal the bacteriological characteristics of the isolates from Balanoposthitis patients, we analysed 47 isolates. In addition, novel clade genotype emm89 S. pyogenes isolates have been reported to be spreading worldwide recently. Hence, we further analysed eight emm89 isolates. Methodology. A drug susceptibility experiment was performed and emm types were determined. More detailed experiments, such as PCR analysis for the presence of virulence-associated genes and MLST analysis, were performed especially using emm89 isolates. Results. All isolates were sensitive to ampicillin, but 34 % of the isolates were resistant to at least one antibiotic. The emm types of the isolates varied, with emm89 and emm11 being the most prevalent, but the emm1 type was not detected. The analysis of emm89 isolates revealed that drug susceptibilities varied. All isolates were negative for the hasABC gene and produced active NADase that are characteristics of novel clade genotype emm89 S. pyogenes. MLST analysis demonstrated that six isolates were of the ST101 type, the most predominant type reported thus far, but two isolates were of the ST646 type. According to the PCR analysis used to determine the presence of streptococcal pyrogenic exotoxin-related genes, the six ST101 isolates were further classified into four groups. Conclusion. These results suggest that Balanoposthitis is caused by a variety of types of S. pyogenes, with novel clade genotype emm89 isolates playing a role in Balanoposthitis infections in Japan.
-
characterization of streptococcus pyogenes isolated from Balanoposthitis patients presumably transmitted by penile oral sexual intercourse
Current Microbiology, 2010Co-Authors: Masaaki Minami, Yukio Wakimoto, Masakado Matsumoto, Hideyuki Matsui, Yasue Kubota, Atsushi Okada, Masanori Isaka, Ichiro Tatsuno, Yasuhito Tanaka, Tadao HasegawaAbstract:Streptococcus pyogenes is indigenous to the human pharynx and causes acute pharyngitis. Balanoposthitis is an inflammatory disease of the glans and the foreskin. However, Balanoposthitis caused by S. pyogenes is not widely recognized as a sexually transmitted disease. In addition, bacteriological features of the isolates causing Balanoposthitis are unclear. The four S. pyogenes strains isolated from adult Balanoposthitis were examined. We performed emm typing, T antigen typing, RAPD assay, PCR assay for the streptococcal pyrogenic exotoxin-related genes and antibiotic-resistant genes, and antibiotic susceptibility assay. All four strains were suspected to be transmitted by penile-oral sexual intercourse, were found to be different by genetic analysis, and also harbored some antibiotic-resistant factors. We propose that S. pyogenes should be considered as a causative agent of sexually transmitted disease. The drug resistant S. pyogenes must be taken into account when Balanoposthitis patients are treated with antibiotic.
